Digestive Diseases and Sciences

, Volume 55, Issue 12, pp 3399–3403 | Cite as

Fully Covered Alimaxx Esophageal Metal Stents in the Endoscopic Treatment of Benign Esophageal Diseases

  • Bahaa E. Senousy
  • Anand R. Gupte
  • Peter V. Draganov
  • Chris E. Forsmark
  • Mihir S. Wagh
Original Article



Expandable esophageal stents are widely used for the palliation of dysphagia in patients with esophageal cancer and are also beginning to be used in patients with benign esophageal diseases such as refractory strictures and fistulas. There is concern regarding the increased risk of migration of the fully covered Alimaxx metal esophageal stent and experience with this stent in benign esophageal pathology has been reported in only a small series of patients.


To evaluate the technical success in placement and removal, efficacy and complications of the Alimaxx esophageal stent for benign esophageal diseases.


Our endoscopy database was retrospectively reviewed from 1/2003 to 2/2009 to identify patients with Alimaxx esophageal stent placement for benign diseases. Chart review was performed for age, gender, indication, site of the lesion, success of placement, outcome, and incidence of complications.


Twenty-eight stents were successfully placed in 14 patients with benign esophageal diseases (mean: two stents/patient; range 1–7). Indications included esophageal fistula in seven (50%) and benign strictures in 7/14 (50%). Dysphagia improved in all patients while the fistula resolved in 6/7 (85.8%) patients. Complications related to stents included pain (2/28, 7%), stent related gastric ulcer (1/28, 4%), nausea and vomiting (3/21, 11%) and stent migration (11/28, 39%). All migrated stents were successfully endoscopically retrieved.


The fully covered and removable Alimaxx stent is effective in the endoscopic management of benign esophageal strictures or fistulas, despite its relatively high rate of migration. Stent migration was successfully managed endoscopically without complications.


Alimaxx Esophageal stent Esophageal fistula Esophageal stricture Completely covered metal stent 


Disclosures/Conflict of interest



  1. 1.
    Schubert D, Scheidbach H, Kuhn R, et al. Endoscopic treatment of thoracic esophageal anastomotic leaks by using silicone-covered, self-expanding polyester stents. Gastrointest Endosc. 2005;61:891–896.CrossRefPubMedGoogle Scholar
  2. 2.
    Davies N, Thomas HG, Eyre-Brook IA. Palliation of dysphagia from inoperable oesophageal carcinoma using Atkinson tubes or self-expanding metal stents. Ann R Coll Surg Engl. 1998;80:394–397.PubMedGoogle Scholar
  3. 3.
    Jagannath S, Canto MI. Endoscopic therapy for advanced esophageal cancer. In: Kochman ML, ed. Endoscopic Oncology: Gastrointestinal Endoscopy and Cancer Management. Totowa, NJ: Humana Press; 2006:53–62.Google Scholar
  4. 4.
    Bethge N, Vakil N. A prospective trial of a new self-expanding plastic stent for malignant esophageal obstruction. Am J Gastroenterol. 2001;96:1350–1354.CrossRefPubMedGoogle Scholar
  5. 5.
    Evrard S, Le Moine O, Lazaraki G, Dormann A, El Nakadi I, Deviere J. Self-expanding plastic stents for benign esophageal lesions. Gastrointest Endosc. 2004;60:894–900.CrossRefPubMedGoogle Scholar
  6. 6.
    Homs MY, Essink-Bot ML, Borsboom GJ, Steyerberg EW, Siersema PD. Quality of life after palliative treatment for oesophageal carcinoma—a prospective comparison between stent placement and single dose brachytherapy. Eur J Cancer. 2004;40:1862–1871.CrossRefPubMedGoogle Scholar
  7. 7.
    Yeaton P, Shami V, Kahaleh M, et al. Reduction in complications leading to recurrent dysphagia using a hybrid esophageal stent—a multi-center retrospective analysis. Gastrointest Endosc. 2007;65:AB280.CrossRefGoogle Scholar
  8. 8.
    Uitdehaag MJ, Hooft JE, Verschuur EM, et al. A fully-covered stent (Alimaxx-E) for the palliation of malignant dysphagia: a prospective follow-up study. Gastrointest Endosc. 2009;70(6):1082–1089.CrossRefPubMedGoogle Scholar
  9. 9.
    Yeaton P, Shami V. Removal of covered, self-expanding nitinol stents in the treatment of benign esophageal diseases. Gastrointest Endosc. 2007;65:AB279.CrossRefGoogle Scholar
  10. 10.
    Lakhtakia S, Reddy N, Dua K. Refractory benign esophageal strictures: continuous, non-permanent dilation with a self-expandable metal esophageal stent (Alimaxx-E). Gastrointest Endosc. 2008;65:AB284.CrossRefGoogle Scholar
  11. 11.
    Eloubeidi MA, Lopes TL. Novel removable internally fully covered self-expanding metal esophageal stent: feasibility, technique of removal, and tissue response in humans. Am J Gastroenterol. 2009;104:1374–1381.CrossRefPubMedGoogle Scholar
  12. 12.
    Pennathur A, Chang AC, McGrath KM, et al. Polyflex expandable stents in the treatment of esophageal disease: initial experience. Ann Thorac Surg. 2008;85:1968–1972.CrossRefPubMedGoogle Scholar
  13. 13.
    Siersema PD, Hop WC, van Blankenstein M, et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc. 2001;54:145–153.PubMedGoogle Scholar
  14. 14.
    Homs MY, Steyerberg EW, Kuipers EJ, et al. Causes and treatment of recurrent dysphagia after self-expanding metal stent placement for palliation of esophageal carcinoma. Endoscopy. 2004;36(10):880–886.CrossRefPubMedGoogle Scholar
  15. 15.
    Conio M, Repici A, Battaglia G, et al. A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia. Am J Gastroenterol. 2007;102(12):2667–2677.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Bahaa E. Senousy
    • 1
  • Anand R. Gupte
    • 1
  • Peter V. Draganov
    • 1
  • Chris E. Forsmark
    • 1
  • Mihir S. Wagh
    • 1
  1. 1.Division of GastroenterologyUniversity of FloridaGainesvilleUSA

Personalised recommendations